hLAG3/hCTLA-4

品系全名

B6.129S-Lag3tm1(hLAG3)Ctla4tm1(hCTLA4)Smoc

目录号

NM-HU-190018

品系状态

活体

导出PDF

品系描述

通过将hLAG3和hCTLA4小鼠交配获得该LAG3和CTLA4双人源化小鼠模型。 双重人源化小鼠模型可用于评估潜在免疫治疗药物组合的功效。
应用领域:免疫治疗;肿瘤研究;药物筛选

你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看